Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{157459,
        author = {Ayush upmanyu},
        title = {Pharmaceutical Patenting In India: Problem Of Public Access To Health},
        journal = {International Journal of Innovative Research in Technology},
        year = {},
        volume = {9},
        number = {7},
        pages = {248-252},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=157459},
        abstract = {India has long been a model for developing countries, adapting drug laws to meet domestic health needs, placing greater emphasis  on the needs of the general public, and thereby responding to their growth. Most of India's population lives below the poverty line, and most of the medical costs have to be paid at their own expense, due to lack of medical care, accessibility, affordability and availability of medicines. Clarifies that is facing a serious health crisis. Indian Patent Law provides for exclusivity under Section 3 (d). "By protecting access to medicines for the poor, the Agreement strikes a good balance between its mission and the Agreement on Trade-related Aspects of International Trade (TRIPS)." },
        keywords = {},
        month = {},
        }